IRIDEX Corp (NASDAQ: IRIX) 10% holder issued 137,333 shares as interest
Rhea-AI Filing Summary
IRIDEX Corp reported an insider ownership change involving a major shareholder. On July 1, 2025, Novel Inspiration International Co., Ltd., identified as a 10% owner of IRIDEX (IRIX), was issued 137,333 shares of common stock.
The Form 4 states that these shares were issued as a quarterly interest payment on a Convertible Promissory Note dated March 19, 2025 between IRIDEX and Novel Inspiration. The shares were received at a stated price of $0.00 per share, and the filing shows 137,333 shares beneficially owned following the transaction, held directly by Novel Inspiration.
The report is filed jointly by Novel Inspiration and Shih-Yao David Lin, who is described as the sole officer, director and stockholder of Novel Inspiration, linking his interests to this 10% ownership position.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock | 137,333 | $0.00 | $0.00 |
Footnotes (3)
- F1. This Form 4 is filed jointly by Novel Inspiration International Co., Ltd. ("Novel Inspiration") and Shih-Yao David Lin. Mr. Lin is the sole officer, director and stockholder of Novel Inspiration.
- F2. The shares were issued as a quarterly interest payment on the Convertible Promissory Note issued March 19, 2025 by the Issuer to Novel Inspiration.
- F3. The shares are owned directly by Novel Inspiration.
FAQ
What insider transaction did IRIDEX (IRIX) disclose in this Form 4?
The filing reports that Novel Inspiration International Co., Ltd., a 10% owner of IRIDEX, was issued 137,333 shares of common stock on July 1, 2025, coded as transaction type J and reported at a price of $0.00 per share.
What is the relationship of the reporting persons to IRIDEX (IRIX)?
The reporting persons, Novel Inspiration International Co., Ltd. and Shih-Yao David Lin, are each identified as 10% owners of IRIDEX under the ownership status section of the report.
AI-generated analysis. How Rhea-AI works. Not financial advice.